The document discusses the quantitative structure-activity relationship (QSAR) approach in drug design, highlighting the importance of identifying and quantifying the physicochemical properties' effects on drug biological activity. It explores the use of linear regression analysis to predict drug interactions and the role of electronic and steric factors in determining compound activity. Additionally, the document introduces 3D-QSAR methods that analyze molecular properties without relying on experimental data, enhancing predictive capabilities for drug design.